Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Dag Aarsland.

Newcastle AuthorsTitleYearFull text
Dr Christina Elliott
Dr Clive Ballard
Dr Dag Aarsland
Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil2023
Dr Paul Donaghy
Dr Dag Aarsland
Dr Joseph Kane
Professor Alan Thomas
Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis2023
Dr Frederic Blanc
Professor John-Paul Taylor
Dr Dag Aarsland
Sex differences in brain atrophy in dementia with Lewy bodies2023
Dr Dag Aarsland
Professor John-Paul Taylor
Julia Schumacher
Professor Ian McKeith
Reactivity of posterior cortical electroencephalographic alpha rhythms during eyes opening in cognitively intact older adults and patients with dementia due to Alzheimer's and Lewy body diseases2022
Dr Dag Aarsland
Professor John O'Brien
Dr Clive Ballard
Professor John Isaacs
Professor Alan Thomas
et al.
Mild cognitive impairment: the Manchester consensus2021
Professor Ian McKeith
Professor Alan Thomas
Dr Frederic Blanc
Professor John O'Brien
Dr Dag Aarsland
et al.
Research criteria for the diagnosis of prodromal dementia with Lewy bodies2020
Professor John-Paul Taylor
Dr Dag Aarsland
The reliability of a deep learning model in clinical out-of-distribution MRI data: A multicohort study2020
Professor Johannes Attems
Dr Dag Aarsland
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration2019
Dr Dag Aarsland
Professor David Burn
Cognition among individuals along a spectrum of increased risk for Parkinson’s disease2018
Dr Dag Aarsland
Professor David Brooks
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease2018
Professor Ian McKeith
Professor John-Paul Taylor
Dr Dag Aarsland
Professor Johannes Attems
Dr Clive Ballard
et al.
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium2017
Dr Dag Aarsland
Professor David Burn
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease2017
Professor John-Paul Taylor
Dr Ruth Cromarty
Dr Dag Aarsland
EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study2016
Professor Johannes Attems
Dr Clive Ballard
Dr Dag Aarsland
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia2016
Dr Clive Ballard
Professor Alan Thomas
Dr Dag Aarsland
Dr Christopher Davison
A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)2015
Dr Dag Aarsland
Professor David Burn
Professor Nicola Pavese
Cognitive Performance and Neuropsychiatric Symptoms in Early, Untreated Parkinson's Disease2015
Dr Clive Ballard
Professor Alan Thomas
Professor John O'Brien
Dr Dag Aarsland
Depression and Synaptic Zinc Regulation in Alzheimer Disease, Dementia with Lewy Bodies, and Parkinson Disease Dementia2015
Dr Dag Aarsland
Professor John-Paul Taylor
Neuropsychiatric aspects of Parkinson’s Disease2015
Professor Johannes Attems
Professor John O'Brien
Dr Dag Aarsland
Dr Clive Ballard
Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias2015
Mary Johnson
Professor Johannes Attems
Dr Clive Ballard
Professor Alan Thomas
Professor John O'Brien
et al.
Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment2014
Mary Johnson
Professor Johannes Attems
Dr Clive Ballard
Professor Alan Thomas
Professor John O'Brien
et al.
Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia2014
Dr Dag Aarsland
Professor David Burn
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines2012
Dr Dag Aarsland
Professor David Burn
Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease2012
Dr Dag Aarsland
Dr Stephen Tyrer
Dr Clive Ballard
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial2012
Dr Michael Firbank
Professor John O'Brien
Dr Dag Aarsland
Multispectral MRI segmentation of age related white matter changes using a cascade of support vector machines2012
Dr Clive Ballard
Dr Dag Aarsland
Dr Brian Saxby
Dr David Lowery
David Green
et al.
Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial2012
Dr Dag Aarsland
Professor David Burn
Dr Liesl Allcock
Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis2010
Dr Iryna Ziabreva
Emeritus Professor Elaine Perry
Dr Clive Ballard
Dr Dag Aarsland
Parkinson Disease With Dementia Comparing Patients With and Without Alzheimer Pathology2009
Dr Clive Ballard
Dr Iryna Ziabreva
Dr Margaret Piggott
Emeritus Professor Robert Perry
Emeritus Professor Elaine Perry
et al.
Cortical Serotonin 1A Receptor Levels Are Associated with Depression in Patients with Dementia with Lewy Bodies and Parkinson's Disease Dementia2008
Dr Dag Aarsland
Professor David Burn
Professor Ian McKeith
Clinical diagnostic criteria for dementia associated with Parkinson's disease2007
Professor David Burn
Dr Dag Aarsland
Professor Ian McKeith
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the Movement Disorder Society Task Force2007
Dr Clive Ballard
Dr Iryna Ziabreva
Emeritus Professor Robert Perry
Professor John O'Brien
Professor Ian McKeith
et al.
Differences in neuropathologic characteristics across the Lewy body dementia spectrum2007
Dr Dag Aarsland
Professor Ian McKeith
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers2007
Dr Iryna Ziabreva
Dr Clive Ballard
Mary Johnson
Professor Ian McKeith
Emeritus Professor Robert Perry
et al.
Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit2007
Dr Iryna Ziabreva
Emeritus Professor Robert Perry
Professor John O'Brien
Professor Ian McKeith
Emeritus Professor Elaine Perry
et al.
Differences in neuropathologic characteristics across the Lewy body dementia spectrum2006
Professor David Burn
Professor Ian McKeith
Dr Dag Aarsland
Ching-Yu Hsu
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease2006
Dr Iryna Ziabreva
Dr Clive Ballard
Dr Dag Aarsland
Professor Ian McKeith
Emeritus Professor Robert Perry
et al.
Lewy body disease: Thalamic cholinergic activity related to dementia and parkinsonism2006
Dr Dag Aarsland
Emeritus Professor Robert Perry
Rate of cognitive decline in PD2006
Dr Iwo Bohr
Dr Iryna Ziabreva
Professor Ian McKeith
Emeritus Professor Robert Perry
Dr Dag Aarsland
et al.
Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation2006
Emeritus Professor Elaine Perry
Dr Iryna Ziabreva
Emeritus Professor Robert Perry
Dr Dag Aarsland
Dr Clive Ballard
et al.
Absence of cholinergic deficits in "pure" vascular dementia2005
Professor Ian McKeith
Professor John O'Brien
Emeritus Professor Elaine Perry
Dr Dag Aarsland
Professor David Burn
et al.
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium2005
Professor Ian McKeith
Professor John O'Brien
Emeritus Professor Elaine Perry
Dr Dag Aarsland
Professor David Burn
et al.
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.[see comment][erratum appears in Neurology. 2005 Dec 27;65(12):1992][summary for patients in Neurology. 2005 Dec 27;65(12):E26-7; PMID: 16380603]2005
Dr Dag Aarsland
Emeritus Professor Robert Perry
Professor Ian McKeith
Professor John O'Brien
Emeritus Professor Elaine Perry
et al.
Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias2005
Dr Dag Aarsland
Emeritus Professor Robert Perry
Dr Clive Ballard
Neuropathology of dementia in Parkinson's disease: A prospective, community-based study2005
Professor Ian McKeith
Dr Dag Aarsland
Professor David Burn
Professor John O'Brien
Dementia with Lewy bodies2004
Professor John O'Brien
Dr Sean Colloby
Dr John Fenwick
Professor David Williams
Dr Michael Firbank
et al.
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with lewy bodies2004
Francesca Cormack
Dr Dag Aarsland
Dr Clive Ballard
Dr Martin Tovee
Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia2004
Dr Dag Aarsland
Dr Urs Mosimann
Professor Ian McKeith
Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies2004
Dr Dag Aarsland
Emeritus Professor Robert Perry
The rate of cognitive decline in Parkinson disease2004
Dr Dag Aarsland
Dr Clive Ballard
Professor Ian McKeith
Professor John O'Brien
Emeritus Professor Robert Perry
et al.
[abstract] Marked neuroleptic sensitivity in dementia with Lewy bodies and Parkinson's disease2003
Dr Clive Ballard
Dr Dag Aarsland
Attention and fluctuating attention in Parkinson's disease with and without dementia and dementia with Lewy bodies2002
Dr Dag Aarsland
Professor Ian McKeith
Professor John O'Brien
Professor David Burn
Dr Timothy Cassidy
et al.
Fluctuations in attention: PD dementia vs DLB with parkinsonism2002
Dr Dag Aarsland
Dr Clive Ballard
Professor Ian McKeith
A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia2001
Dr Dag Aarsland
Dr Clive Ballard
Professor Ian McKeith
Emeritus Professor Robert Perry
Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease2001